A. Maderer, “CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset”, AO, vol. 60, no. 11, pp. 1543–1547, Nov. 2021.